NCT04553471View on ClinicalTrials.gov

Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

May 4, 2023

Conditions
SarcomaThoracic CancerAbdominal CancerPelvic Cancer
Interventions
RADIATION

Stereotactic body radiotherapy

Treatment will take approximately 2 weeks.

PROCEDURE

Research blood draw

-Baseline, immediately after radiotherapy completion (fraction 5), 14 days after radiotherapy, and 30 day follow-up

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

Goldman Sachs Foundation (Emerson Collective)

UNKNOWN

lead

Washington University School of Medicine

OTHER

NCT04553471 - Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers | Biotech Hunter | Biotech Hunter